Does HBV infection increase risk of endometrial carcinoma?

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 713-716

  Jiang, Xue Feng ^a   Tang, Qiong Lan ^b   Zou, Yuan ^c   Xu, Ling ^d   Zeng, Hua ^b   Chi, Cong ^a   Jiang, Jing Ru ^a   Zhang, Bin Zhong ^b  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^d Guangzhou Women and Children's Medical Center   (China)

Author keywords

Endometrial carcinoma; Hepatitis B; Serum markers

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CHINA; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MIDDLE AGED; PATHOGENICITY; PREVALENCE; PROGNOSIS; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROGNOSIS;

EID: 84894666479     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.713     Document Type: Article

References (22)

1. Becker N, Schnitzler P, Boffetta P, et al (2012). Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol, 138, 1993-2001.
2. Campagnoli C, Abbà C, Ambroggio S et al (2013). Life-style and metformin for the prevention of endometrial pathology in postmenopausal women. Gynecol Endocrinol, 29, 119-24.
3. Creasman W (2009). Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet, 105, 109.
4. Hsu CS, Liu CH, Wang CC, et al (2012). Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat, 19, e48-57.
5. Iavarone M, Colombo M (2013). HBV infection and hepatocellular carcinoma. Clin Liver Dis, 17, 375-97.
6. Jiang XF, Tang QL, Li HG, et al (2013). Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. J Obstet Gynaecol Res, 39, 855-63.
7. Jiang XF, Tang QL, Shen XM, et al (2012). Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma. Pathol Res Pract, 208, 730-5.
8. Jin Y, Gao H, Chen H, et al (2013). Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues. Cancer Lett, 335, 447-54.
9. King LY, Chung RT (2010). When treating cancer, please don't forget hepatitis B. Oncologist, 15, 826-9.
10. Liang X, Bi S, Yang W, et al (2009). Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine, 27, 6550-7.
11. Liu J, Fan D (2007). Hepatitis B in China. Lancet, 369, 1582-3.
12. Mantovani A (2005). Cancer: Inflammation by remote control. Nature, 435, 752-3.
13. Mason A (2006). Role of viral replication in extrahepatic syndromes related to hepatitis B virus infection. Minerva Gastroenterol Dietol, 52, 53-66.
14. Mason A, Wick M, White H, et al (1993). Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology, 18, 781-9.
15. Ocana S, Casas ML, Buhigas I, et al (2011). Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol, 17, 1553-7.
16. Park SH, Kim DJ, Lee HY (2009). Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection. Am J Gastroenterol, 104, 1135-39.
17. Siu SS, Cheung TH, Chan PK, et al (2007). Patients with malignant or pre-malignant cervical lesion have increased risk of becoming hepatitis B carrier. J Exp Clin Cancer Res, 26, 77-81.
18. Sorrell MF, Belongia EA, Costa J, et al (2009). National Institutes of Health Consensus Development Conference statement: Management of hepatitis B. Ann Intern Med, 150, 104-10.
19. Terrier B, Cacoub P (2011). Hepatitis B virus, extrahepatic immunologic manifestations and risk of viral reactivation. Rev Med Intern, 32, 622-7.
20. Uchida T, Kaneita Y, Gotoh K, et al (1997). Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol, 52, 399-405.
21. Yeo W, Chan PK, Hui P et al (2003). Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study. J Med Virol, 70, 553-61.
22. Zur Hausen H (1999). Viruses in Human Cancers. Eur J Cancer, 35, 1174-81.